Subsequently, the subpopulation of cells undergoing mesenchymal transition was investigated by examining the expression of CD133, recognized as a potential marker for EMT and cancer stemness in various cancers, including pancreatic cancer (23, 24). Here, PROM1 is linked to cancer.